Teijin Limited (TINLF) Research

Teijin Limited, a global enterprise established in Tokyo, Japan, in 1918, operates across multiple key sectors including fibers, films, composites, healthcare, and IT. The company's advanced materials portfolio encompasses various fibers such as aramid, carbon, and polyester, alongside specialized films like polycarbonate and high-density polyethylene. It also produces resins, molded parts, and additives, as well as lightweight glass and carbon fiber reinforced composites, particularly for automotive applications. In the healthcare domain, Teijin develops pharmaceuticals addressing a range of conditions, including bone and joint, respiratory, and cardiovascular diseases. It further provides medical devices for home oxygen therapy, non-invasive ventilation, rehabilitation, and sleep disorders, complemented by orthopedic implants and functional food ingredients. Beyond materials and healthcare, Teijin offers IT solutions like Recopic, an RFID technology for inventory management. The company also leverages its engineering expertise to address global issues such as environmental pollution, energy supply stability, and challenges associated with an aging workforce population.

Open Teijin Limited (TINLF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.